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Summary
Background Passively collected malaria case data are the foundation for public health decision making. However, 
because of population-level immunity, infections might not always be sufficiently symptomatic to prompt individuals 
to seek care. Understanding the proportion of all Plasmodium spp infections expected to be detected by the health 
system becomes particularly paramount in elimination settings. The aim of this study was to determine the association 
between the proportion of infections detected and transmission intensity for Plasmodium falciparum and Plasmodium 
vivax in several global endemic settings.
Methods The proportion of infections detected in routine malaria data, P(Detect), was derived from paired household 
cross-sectional survey and routinely collected malaria data within health facilities. P(Detect) was estimated using a 
Bayesian model in 431 clusters spanning the Americas, Africa, and Asia. The association between P(Detect) and 
malaria prevalence was assessed using log-linear regression models. Changes in P(Detect) over time were evaluated 
using data from 13 timepoints over 2 years from The Gambia.
Findings The median estimated P(Detect) across all clusters was 12⋅5% (IQR 5⋅3–25⋅0) for P falciparum and 10⋅1% 
(5⋅0–18⋅3) for P vivax and decreased as the estimated log-PCR community prevalence increased (adjusted odds ratio 
[OR] for P falciparum 0⋅63, 95% CI 0⋅57–0⋅69; adjusted OR for P vivax 0⋅52, 0⋅47–0⋅57). Factors associated with 
increasing P(Detect) included smaller catchment population size, high transmission season, improved care-seeking 
behaviour by infected individuals, and recent increases (within the previous year) in transmission intensity.
Interpretation The proportion of all infections detected within health systems increases once transmission intensity 
is sufficiently low. The likely explanation for P falciparum is that reduced exposure to infection leads to lower levels of 
protective immunity in the population, increasing the likelihood that infected individuals will become symptomatic 
and seek care. These factors might also be true for P vivax but a better understanding of the transmission biology is 
needed to attribute likely reasons for the observed trend. In low transmission and pre-elimination settings, enhancing 
access to care and improvements in care-seeking behaviour of infected individuals will lead to an increased proportion 
of infections detected in the community and might contribute to accelerating the interruption of transmission.
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Introduction
For diseases such as malaria, infections do not always lead 
to clinical manifestations and clinical symptoms might 
not be caused by the parasitic infection. Thus, passive case 
detection (PCD) data will underestimate the true 
magnitude of infections.1–3 Despite efforts to ensure that 
all confirmed care-seeking malaria infections are captured 
as part of PCD, little is known about the potential 
implications of uncounted asymptomatic infections on 
estimates of malaria infections. This undercounting could 
help to explain why global estimates of malaria vary 
substantially depending on how these hidden infections 
are counted.4 Accounting for asymptomatic infections is 
especially important in malaria elimination settings: 
targeted interventions might be implemented before 
transmission is low enough for them to be effective, and 
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any residual infections provide a source for onward 
transmission.5,6
Asymptomatic malaria infections are common in 
endemic areas; patients with such infections are not 
expected to seek care and consequently the infections are 
not detectable by malaria surveillance activities.7,8 The 
presence and persistence of asymptomatic infections is 
a complex phenomenon related to levels of protective 
immunity acquired with repeated exposure to malaria and 
the maturity of the immune system.9 If an individual is 
not sufficiently symptomatic to prompt care seeking or if 
parasite densities are not sufficiently high to be detected 
using rapid diagnostic tests or microscopy—the routinely 
used diagnostics for confirming malaria infections in 
people with clinical symptoms—they cannot be detected 
within routine aggregation of PCD data as part of malaria 
surveillance activities.10 Understanding the magnitude 
of under counting, and if or when all infections in a 
community are expected to become symptomatic and 
therefore passively detectable, becomes paramount for 
settings aiming to achieve malaria elimination.
We did a pooled analysis of paired cross-sectional 
household surveys and routinely collected PCD data for 
both Plasmodium falciparum and Plasmodium vivax to 
assess the impact of asymptomatic infections on the 
interpretation of malaria surveillance data and factors 
affecting any associations with transmission intensity. 
The relation between the proportion of all infections 
detected in health systems—P(Detect)—and the parasite 
reservoir in the community as estimated by PCR, 
used here as a proxy for transmission intensity and the 
expected levels of protective immunity in the population,9 
and any changes over time were examined.
Methods
Literature review and data collection
A literature review was done by GS using the search terms 
“Plasmodium” AND “cross sectional survey” to identify 
community-based cross-sectional household surveys for 
P falciparum infection in which data collection was done 
either at a single or multiple timepoints. Any poten tially 
eligible study identified in PubMed or Embase, irre s pective 
of publication date, was assessed for eligibility. We sought 
studies that reported or could extrapolate all-age malaria 
prevalence in the community, diagnosed either via 
molecular methods or estimated from rapid diagnostic test 
data using validated methods.8,11–13 Studies were excluded 
if any of the following criteria were met: the sampled popu-
lation was not comprised of randomly selected households; 
only a subset of individuals residing in the selected 
Research in context
Evidence before this study
A strong surveillance system is a core intervention in the global 
strategy for malaria control and elimination. Despite recent 
progress in strengthening the quality of the data generated in 
health systems, research suggests that a sizeable population of 
individuals with asymptomatic infections who do not seek 
medical care are present in most endemic settings. By not 
accounting for these infections, malaria burden is underestimated. 
The probability that an individual becomes symptomatic for 
Plasmodium falciparum malaria is a function of the protective 
immunity acquired over repeated exposure to malaria. Therefore, 
the magnitude of the potential undercounting in estimates of 
malaria burden that rely on routinely collected data would likely be 
a function of transmission intensity, whereby the effectiveness of 
the health system in detecting malaria infections should improve 
as transmission intensity and population-level immunity to 
malaria decrease. However, previous studies have not been able to 
directly assess this issue outside of modelling frameworks. Based 
on a search of the PubMed and Embase databases in English and 
French from inception to Dec 31, 2018, using general search terms 
“malaria”, “epidemiology”, and “polymerase chain reaction [PCR]”, 
no database of paired community survey and health systems for 
either Plasmodium falciparum or Plasmodium vivax data covering 
a range of transmission intensities exists.
Added value of this study
Our work has created a database consisting of 431 and 
213 paired PCR prevalence and clinical incidence data covering 
13 and seven countries for P falciparum and P vivax, respectively, 
in three endemic regions. We found that, on average, health 
systems detect only a small fraction of all infections, with the 
heath system effectiveness improving at the lowest range of 
transmission intensity. Factors associated with an improved 
proportion of infections detected included being in the high 
transmission season, smaller catchment population sizes, 
care-seeking behaviours, and a recent change of transmission 
as a proxy for the expected levels of population-level protective 
immunity.
Implications of all the available evidence
Our results are the first data estimating the proportion of malaria 
infections expected to be symptomatic and seek care and the 
potential magnitude of the undercounting associated with 
asymptomatic infections in quantifying malaria transmission 
intensity. The evidence suggests that the health system becomes 
more effective at detecting malaria infections once transmission 
intensity is sufficiently low. Where the goal is to eliminate malaria 
transmission, the notion that the health system becomes more 
effective at detecting infections when transmission is low is 
reassuring. Improving access to care for testing and promoting 
better care-seeking behaviour of infected individuals would lead 
to more infections being detected. For settings accelerating 
malaria elimination, this confidence that any infections are likely 
to be sufficiently symptomatic to seek care becomes especially 
relevant whereby any residual population-level protective 
immunity has the potential to mask any lingering or introduced 
infections and could lead to programmes failing to sustain 
interruption of transmission.
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households were tested for malaria; the passive surveil-
lance data from health facilities could not be obtained 
within the timeframe of the study; or it was not possible 
to match the individuals represented in the health 
facility and community survey data in geographical 
space and therefore represent the same target population 
(appendix pp 1–2). If the community data were available in 
the required format, the study authors were contacted to 
request access to the data and to ask whether the paired 
health facility data were available and could be accessed. 
Searches were limited to abstracts or titles written in 
English or French.14 Unpublished data were also sought by 
asking investigators for studies that met our inclusion 
criteria, which consisted of any cross-sectional surveys 
using randomly selected household as the sampling unit.
Household survey data
For the household survey data, access to the individual-
level community survey data was requested from 
the corresponding authors. The primary focus was on 
P falciparum, but P vivax data were gathered when 
available. The data collected from the household survey 
were used both to estimate the total number of infected 
individuals likely to be within the catchment population 
and the current transmission intensity. Alternative 
methods for deter mining transmission intensity are 
possible, but all methods lead to consistent estimates; for 
this study, we used prevalence because it was available 
for all clusters.15,16 The variables requested were malaria 
test result, diagnostic method, age, sex, geographical 
coordi nates for the household, survey date, recent 
malaria control interventions in the population, and total 
population size. In cases where the same population 
was sampled at different timepoints, baseline data were 
included as well as data from subsequent surveys 
representing different periods of seasonal transmission, 
with the high malaria season typically associated with 
periods of intense rains.
PCD data
The existence of PCD data already linked to the community 
surveys was not an essential criterion for inclusion. If 
not available as part of the study design, the ability to 
retrospectively extract the required PCD data from the 
relevant facilities or existing databases was required. 
Variables collected from the routinely reported PCD data 
included the number of confirmed malaria cases reported 
over the time period matching the commu nity survey, 
diagnostic method, and geo referencing information for 
patient households where needed to match the two 
populations. Any imported cases, as classified according 
to the local guidelines, were excluded from the analysis 
because such cases do not represent local transmission. 
Any case identified in the week before and after completion 
of the community-based data collection was included to 
account for any delays in treatment seeking or the intrinsic 
incubation period whereby an infection in the community 
can represent a transmission event occurring within 
1 week before or after data collection.
Spatial matching was done to ensure comparability 
between the populations under analysis. The community 
survey design and availability of routine data on facility 
catchment boundaries determined the approach 
(appendix p 1). For most studies, catchment areas were 
overlapping and therefore no data adjustment was 
necessary. For the single study with non-overlapping 
populations and for which spatial information was 
available, geolocation data were extracted from the health 
facility registers for each case, which were collected as 
part of a concurrent cluster randomised trial.6 For any 
studies identified in the literature where this match was 
not good and geolocation information was not available, 
the site was excluded. Using the available information, 
populations for both datasets were restricted to those 
overlapping in space (appendix p 2). The number of 
confirmed cases in the populations younger than or older 
than 5 years of age, as defined by the routine aggregation 
of malaria data, was also collected where available.1
Covariate data
Covariates of interest included reported insecticide-treated 
bednet use the previous night, whether or not the house 
had been treated with indoor residual spray in the past 
12 months, self-reported health care-seeking behaviour for 
fevers, and any recent study-implemented intervention 
that had taken place. Covariate data were obtained 
from the cross-sectional surveys if available. When these 
surveys were not available, data were extrac ted from 
the geostatistical models developed by the Malaria Atlas 
P falciparum (clusters, n) P vivax (clusters, n)
All ages Individuals 
older than 
5 years
Children 
aged 5 years 
and younger
All ages Individuals 
older than 
5 years
Children 
aged 5 years 
and younger
Brazil 6 6 6 6* 6* 6*
Cambodia 34 20 20 7 7 ··
Ethiopia 1 ·· ·· 1 ·· ··
The Gambia 36 34 34 ·· ·· ··
Haiti 14 14 10 ·· ·· ··
Kenya 10 9 9 ·· ·· ··
Laos 17 17 17 17 17 17
Malaysia 7 6 6 7 ·· ··
Myanmar 199 199 ·· 171 171 ··
Peru 7 ·· ·· ·· ·· ··
Philippines 4 ·· ·· 4 ·· ··
Tanzania 25 4 4 ·· ·· ··
Zambia 111 ·· 95 ·· ··
Total 471 309 201 213 201 23
The table shows the clusters for which data from all ages as well as data focusing only on those older than 5 years of 
age or children 5 years of age and younger were available for analysis. Studies covered the period from 2008 to 2017. 
*Two of the clusters are different from those reporting P falciparum.
Table 1: Numbers of paired community survey and health facility clusters available for both the 
Plasmodium falciparum and Plasmodium vivax analysis in each country
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Project (MAP) from the time and location of data 
collection.13,17 If gaps remained, expert opinion was sought 
from the study investigators. Recent changes in trans-
mission intensity in the studied population were quantified 
by using the predicted annual P falciparum incidence 
according to the MAP models for the year and location of 
the survey. The difference in P falciparum incidence 
between the study year and that estimated 1 year and 
5 years previously was calculated and included as a 
covariate to capture any potential mismatch between 
current transmission intensity and expected population-
level protective immunity. These data were not available 
for P vivax.
Ethics approval for all secondary use of data and 
collection of passively collected data was obtained from 
the London School of Hygiene & Tropical Medicine (ethics 
approval number 14320). If required, additional local 
ethics approval was also obtained for this specific analysis 
(ethics approval numbers RITM-170818, UnzaRec-1131, 
NBC Haiti-1516-29, and 1617-31). Approvals for the original 
data collection are reported in the site-specific publications 
(appendix pp 3–4).
Derivation of P(Detect)
The main outcome of interest was P(Detect) per study 
cluster, wherein a cluster consists of a paired health facility 
and community population. Data used to derive the esti-
mates included the number of cases detected at the health 
facility, the number of people infected, the number 
sampled in the community survey, and the total population 
of the community. Mixed infections identified were 
included in the species-specific analysis, but too few were 
reported to be assessed as a separate outcome. Briefly, to 
account for the zero-inflated distribution of case counts, 
Bayesian methods based on a Polya Urn model for finite 
populations were used to estimate P(Detect) and corres-
ponding levels of uncertainty. The simulation algorithm 
was implemented in the R software (version 3.3) using the 
polyapost package (appendix pp 5–7).
Longitudinal data
Data from 13 monthly surveys over 2 years collected in 
The Gambia were used to assess seasonal trends in 
P(Detect).18 P(Detect) was estimated in each study village 
for each month of data collection. The resulting estimates 
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Figure 1: Estimated proportion of Plasmodium falciparum infections in 
populations detected within health systems (P[Detect]) compared with the 
corresponding prevalence of infection in the community
(A) All age groups. (B) Individuals older than 5 years of age. (C) Children aged 
5 years and younger, with the significant interaction in non-African and African 
populations shown in the separate panels. The average fitted linear mixed model 
trend is shown by the red line and corresponding 95% CI band is shaded in grey. 
Each dot represents a paired community and health facility cluster, with their size 
representing the sample size of the community survey as small (<50 people), 
medium (50–100 people), or large (>150 people). The 95% credible intervals around 
each metric are shown by the horizontal and vertical grey lines around each cluster.
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were plotted over time with the locally estimated scatter-
plot smoothing fit used to assess the average trend across 
all villages and stratified according to low (estimated 
PCR prevalence below 8⋅0%) or high transmission 
intensity (above 8⋅0%).
Statistical analysis
Log-linear regression was conducted with the lme4 
package for the R software. The dependent variable 
was the logit of P(Detect) with a Gaussian family and 
the independent variable was community-level PCR 
pre valence. Random-effects models were used to 
account for the effect of the study cluster in the 
P falciparum surveys; these model fits resulted in 
minimal improve ment for P vivax data, so fixed-effects 
models were employed for P vivax. Models were 
estimated according to the restricted maximum likel-
ihood estimation method for com putational efficiency. 
Covariates, interaction terms, and splines were tested 
with the best model fit ascertained according to 
the Akaike Information Criterion value. The log odds 
esti mates were back-transformed to prevalence for 
ease of interpretation and the average model fit 
and corres ponding uncertainty were plotted for 
visualisation.
Role of the funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author 
had full access to all the data in the study and had 
final responsibility for the decision to submit for 
publication.
Results
Our search for published and unpublished studies 
resulted in data from 471 clusters in 13 countries for 
P falciparum and 213 clusters in seven countries for 
P vivax (table 1, appendix p 8). The malaria diagnostic 
used in most clusters was ultrasensitive PCR (in 250/471 
for P falciparum and in 194/213 for P vivax), which has a 
limit of detection that is 50-times more sensitive than that 
of conventional PCR.19 132 clusters from two countries 
(Zambia [n=111] and Tanzania [n=21]) required adjust-
ment because only rapid diagnostic test data were 
available.8 PCD data representing individuals older than 
5 years of age were available for 309 clusters for 
P falciparum and 201 clusters for P vivax, and data 
for children aged 5 years and younger in 201 clusters for 
P falciparum and 23 clusters for P vivax. The discrepancy 
in the number of clusters is due to clusters for which age 
adjustment was required being excluded from the age-
specific analysis.
For P falciparum malaria, the cluster-level all-age esti-
mated PCR prevalence was 16⋅17% (95% CI 14⋅43–17⋅91), 
ranging from 0⋅04% to 79⋅74%. The 471 clusters had a 
median size of 511 people (IQR 148–4724) but ranged 
from 24 to 100 000 individuals, with the fraction sampled 
between 0⋅03% (8/22 988) and 99⋅2% (392/418) of 
the population. The median estimated P(Detect) was 
12⋅5% (IQR 5⋅3–25⋅0). There was a negative association 
between P(Detect) and estimated PCR prevalence in 
the community (adjusted odds ratio [OR] 0⋅63, 95% CI 
0⋅57–0⋅69; figure 1A; appendix pp 9–10). Health facilities 
had lower odds of detecting infections in larger than 
in smaller communities (adjusted OR 0⋅23, 95% CI 
0⋅17–0⋅31), during the low transmission season (0⋅59, 
All ages (n=471 clusters) Individuals older than 5 years 
(n=309 clusters)
Children aged 5 years and 
younger (n=201 clusters)
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Intercept 3·80 (1·65–8·73) 0·0021 0·01 (0·006–0·02) <0·0001 0·36 (0·22–0·58) 0·0001
Log odds community prevalence 0·63 (0·57–0·69) <0·0001 0·58 (0·53–0·64) <0·0001 1·04 (0·89–1·22) 0·61
Non-African region (vs African countries) 0·37 (0·22–0·62) 0·0003 4·45 (2·00–9·89) 0·0004 0·08 (0·02–0·29) 0·0002
Log
10
 population size 0·23 (0·17–0·31) <0·0001 ·· ·· ·· ··
Low transmission season 
(vs high transmission system)
0·59 (0·46–0·77) 0·0001 0·65 (0·53–0·80) 0·0001 0·62 (0·44–0·87) 0·0067
RDT used as community diagnostic 
(vs PCR)
4·27 (2·31–7·90) <0·0001 0·07 (0·03–0·14) <0·0001 ·· ··
Increase in malaria incidence in the 
previous year
431·82 (2·07–89859·3) 0·028 ·· ·· ·· ··
Log odds p (seek care if febrile)* ·· ·· 0·71 (0·58–0·87) 0·0015 0·85 (0·71–1·01) 0·075
Log odds community prevalence: region ·· ·· ·· ·· 0·55 (0·42–0·73) 0·0001
Log odds bednet use ·· ·· 2·29 (1·16–2·37) 0·024 ·· ··
Detection of infection in the full all-age population, in the populations aged older than 5 years, and in children aged 5 years and younger is shown. Some cells are 
empty because the factor was not retained in the adjusted analysis because they did not contribute to the explanatory power of the model. OR=odds ratio. RDT=rapid 
diagnostic test. *The probability of patients seeking care if febrile is the proxy variable typically used in malaria research to provide a proxy estimate for treatment 
seeking.
Table 2: Fixed-effects results of the mixed-effects log-linear regression for the proportion of Plasmodium falciparum infections detected in the health 
system according to community-level transmission intensity
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0⋅46–0·77), and in non-African compared with African 
settings (0⋅37, 0⋅22–0⋅62). Settings in which malaria 
incidence had increased in the year before the survey 
were more likely to have infections detected (adjusted 
OR 431⋅82, 95% CI 2⋅07–89859·3; table 2).
Within the 309 clusters with data on infections in those 
older than 5 years of age, a similar but more extreme 
trend was observed as that for the all-age population, 
whereby most infections remained unrepresented at the 
facility level until reaching the lowest levels of estimated 
PCR prevalence (figure 1B). In the population older than 
5 years of age, health facilities had an increased odds 
of detecting infections in non-African settings compared 
with African settings (adjusted OR 4⋅45, 95% CI 
2⋅00–9⋅89), and where there was a higher reported use 
of insecticide-treated bednets in the population (2⋅29, 
1⋅16–2⋅37). There were lower odds of infections detected 
within health facilities during the low transmission 
season than in the high transmission season (adjusted 
OR 0⋅65, 95% CI 0⋅53–0⋅80; table 2).
The odds of detecting infections in health facilities in 
children aged 5 years and younger also showed a negative 
association with estimated community PCR prevalence, 
but there was a significant interaction by region (figure 1C). 
The relation in African settings showed a slight positive 
association with transmission intensity. By contrast, 
the relation in non-African settings was similar to that 
observed in the population older than 5 years of age, with 
an increase in P(Detect) once estimated prevalence was 
sufficiently low (figure 1C; appendix pp 9–10). Similar 
factors to the other models were associated with P(Detect) 
and the odds of detecting infections were lower during the 
low trans mission season (adjusted OR 0⋅62, 95% CI 
0⋅44–0⋅87; table 2).
The seasonal pattern in P(Detect) was specifically 
assessed using a longitudinal dataset with 12 villages in 
The Gambia with paired PCD and community data 
spanning 2 years. Annual village-level estimated PCR 
prevalence ranged from 2⋅29% to 24⋅18% (figure 2). 
Overall, monthly estimates of P(Detect) ranged from 
0⋅57% to 82⋅05%, with the largest within-village variation 
observed in village L (ranging from 3⋅33% to 82⋅05%; 
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Figure 2: Estimated proportion of Plasmodium falciparum infections in 
populations detected within health systems (P[Detect]) in 12 communities 
sampled at 13 monthly intervals over 2 years in The Gambia
(A) The annual variation within each study village (A to M) is shown as a boxplot, 
with low transmission villages represented in orange and high transmission 
villages in blue. (B) The locally estimated scatter plot smoothing (LOESS) trends for 
all villages combined with the different colours representing the 12 individual 
villages. (C) The LOESS trends for villages stratified according to high transmission 
intensity (blue line) or low transmission intensity (orange line). The 95% CIs from 
the LOESS estimate are shown as the shaded grey area. The 95% credible intervals 
around P(Detect) are shown by the vertical grey lines around each, with the point 
size representing the estimated community prevalence for that sample month. 
The dashed vertical red line identifies the period where a mass drug 
administration of dihydroartemisinin–piperaquine was deployed in all 
study villages.18
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figure 2A). A seasonal pattern whereby P(Detect) in-
creases during the high transmission season (usually 
September–December) was evident (figure 2B). When 
stratified by villages with high (n=4) and low (n=8) trans-
mission intensity, a similar seasonal pattern emerged 
(figure 2C).
For P vivax malaria, mean cluster-level all-age estimated 
PCR prevalence was 14⋅47% (95% CI 12⋅5–16⋅37) but 
ranged from 0⋅05% to 93⋅75%. The 213 clusters of 
paired data ranged in size from 24 to 20 841 individuals 
with the fraction sampled between 0⋅02% (82/4168) and 
94⋅44% (51/54) of the population. The median estimated 
P(Detect) was 10⋅1% (IQR 5⋅0–18⋅3). Again, there was 
evidence of a negative association between P(Detect) and 
estimated PCR prevalence in the community (adjusted 
OR 0⋅52, 95% CI 0⋅47–0⋅57; figure 3A, appendix pp 9–10). 
There were lower odds of detecting infections in Asian 
than in non-Asian settings (adjusted OR 0⋅05, 95% CI 
0⋅02–0⋅12) and lower odds of detecting infections in 
larger than in smaller populations (0⋅23, 0⋅17–0⋅32). 
P(Detect) was also likely to increase in communities in 
which ultrasensitive PCR was used as the diagnostic tool 
when compared with communities where malaria was 
assessed using other PCR methods (adjusted OR 4⋅09, 
95% CI 2⋅12–7⋅90; table 3).
When examining the 201 clusters with data about 
P vivax infections in the population aged older than 
5 years, a similar trend was observed to that in the all-age 
population, with most infections remaining undetected 
until the lowest estimates of estimated PCR prevalence 
(adjusted OR 0⋅51, 95% CI 0⋅47–0⋅56; figure 3B, 
appendix pp 9–10). Infections in those aged older than 
5 years were more likely to be detected at health facilities 
where a recent intervention (mass drug administrations 
targeting P falciparum with or without concurrent long-
lasting insecticidal net distribution) took place than in 
those without a recent intervention (adjusted OR 1⋅56, 
95% CI 1⋅01–2⋅41), and where the probability of 
individuals seeking care if febrile was higher (1⋅95, 
1⋅46–2⋅60). There were lower odds of infections being 
detected in larger than in smaller communities (adjusted 
OR 0⋅22, 95% CI 0⋅16–0⋅31; table 3). In the 23 clusters 
with data available for P vivax infections in children aged 
5 years and younger, a similar trend to that seen in all ages 
as well as individuals older than 5 years was observed; 
however, the number of clusters was in sufficient for 
further analysis (appendix p 11). Results of the validation 
tests for all models suggest a good predictive capacity 
(appendix pp 12–14).
Discussion
The presence of asymptomatic infections across the 
malaria transmission spectrum has been well established 
but not adequately quantified.8 Irrespective of issues 
related to health system capacity, such infections are not 
typically captured as part of routine passive surveillance. 
Using paired health facility and cross-sectional survey 
data, we have described the extent to which malaria is 
underestimated due to the prevalence of asymptomatic 
infections for both P falciparum and P vivax malaria when 
relying solely on malaria surveillance data, providing a 
proxy measure for the proportion of infections that are 
symptomatic enough for infected individuals to seek care. 
Crucially, we have shown how this association changes as 
transmission intensity decreases. Although for malaria 
control programmes to know the true transmission 
intensity will be difficult, as will ascertaining whether 
or not the clinical symptoms driving care-seeking are 
attributable to malaria, the observation that more 
infections are identified within the health facility once 
0
P(
De
te
ct
), 
(%
)
25
50
75
100
A
0 10 20 30 40 50 60 70
0
P(
De
te
ct
), 
(%
)
Estimated community prevalence (%)
25
50
75
100
B
Figure 3: Estimated proportion of Plasmodium vivax infections detected in health facilities compared with the 
corresponding prevalence of infection in the community
(A) All age groups. (B) Individuals older than 5 years of age. The average fitted linear mixed model trend is shown 
by the red line and corresponding 95% CI band is shaded in grey. Each dot represents a paired community and 
health facility cluster, with their size representing the sample size of the community survey as small (<50 people), 
medium (50–100 people), or large (>150 people). The 95% credible intervals around each metric are shown by the 
horizontal and vertical grey lines around each cluster.
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transmission is sufficiently low (eg, a higher estimated 
P[Detect]) is reassuring.20
The observed pattern for P falciparum is consistent with 
the expected levels of population-level immunity.9 Proxy 
measures for immunity were consistently found to be 
important factors associated with P(Detect). First, an 
increase in transmission during the past year was 
positively associated with the proportion of infections 
detected. In such settings, a higher proportion of sus-
ceptible individuals would be expected given the current 
estimated levels of transmission and these individuals 
therefore have an increased likelihood of becoming 
symptomatic.3,21 Second, compared with non-African sites, 
African settings tended to have a lower P(Detect). Different 
global regions have had very different malaria histories, 
with malaria transmission in Africa being much higher 
for longer than in America or Asia, meaning that different 
levels of population immunity are expected.4 Third, the 
interaction between prevalence and region in children 
further supports this notion, with the estimated P(Detect) 
in children generally being higher than in adults and 
remaining relatively constant across the range of estimated 
PCR prevalence. Children are less likely than adults to 
have acquired sufficient immunity to protect against 
symptoms and are therefore more likely to become 
sufficiently symptomatic to prompt care-seeking.9 This 
theory is further reinforced by the slight increase in 
P(Detect) in African children as transmission intensity 
increases. This trend could represent opportunistically 
detected malaria infections in children acquiring sufficient 
levels of protective immunity earlier in life, meaning that 
the fever prompting care-seeking might not be causally 
related to their malaria infection.
The observed association is less straightforward when 
considering P vivax. The factors probably contributing 
to the negative association between P(Detect) and 
transmission intensity might be affected by several, 
non-mutually exclusive factors. First, P vivax infections 
typically have lower parasite densities than P falciparum 
infections.22 Such lower parasite densities might be 
related to fewer infections being sufficiently symptomatic 
to prompt care-seeking and fewer infections that are 
expected to be infectious.23 Furthermore, even if someone 
does seek care, the routine diagnostic tests for P vivax are 
currently less sensitive than those for P falciparum: thus, 
infections might not be confirmed even if infected 
individuals are presenting to a health-care facility and 
tested.22 Next, although natural acquired immunity to 
P vivax is likely, the degree of the protection obtained and 
effect of hypnozoites on the probability that an infected 
individual will become symptomatic is not well under-
stood. In areas with co-circulating parasite strains, efforts 
might also be biased towards P falciparum, which is 
traditionally the focus of malaria control and elimination 
programmes. The perception of risk for P vivax might 
differ to that for P falciparum infections, which alters care-
seeking and diagnostic behaviours. Moreover, there 
might be sufficient cross-protection between the species, 
modi fying the likelihood that an infection from either 
species would elicit symptoms.24
Across the settings examined, P(Detect) varied sub-
stantially, with health facilities in 27 clusters across six 
countries detecting at least half of all P falciparum 
infections and health facilities in nine clusters across 
three countries detecting at least half of all P vivax 
infections. Two factors that were consistently associated 
with a reduced probability that an infection will be 
detected within the health facility were the facility 
catchment population size and the transmission season. 
Intuitively, detecting one infection will be easier in 
20 people than in 2000 people. Similarly, seasonality was 
defined according to the specific setting and parasite 
species. In the low transmission season, when vector 
densities are low, a malaria parasite might be more geared 
towards surviving until the next transmission season 
than causing clinical symptoms that could lead to 
treatment. The protective immunity acquired during the 
previous transmission season might also have not yet 
sufficiently waned for symptoms to develop, suggesting a 
lower probability of becoming symptomatic and therefore 
a lower estimated P(Detect).25 It is also plausible that 
clinicians would be less likely to test for malaria or 
patients less likely to seek care for a fever when malaria is 
not perceived to be a problem.26 These findings reinforce 
the view that good access to testing and treatment 
practices improves detection of malaria infections and a 
better understanding of malaria-attributable fevers could 
improve clinical algorithms that account for any seasonal 
changes in malaria presentation.5,27,28 In settings 
where blood-stage malaria vaccines or other interventions 
reduce the likelihood of an individual becoming 
sufficiently symptomatic to seek care, the proportion of 
All ages (n=213 clusters) Individuals older than 5 years of 
age (n=201 clusters)
Adjusted OR 
(95% CI)
p value Adjusted OR 
(95% CI)
p value
Intercept 2·72 (0·94–7·92) 0·067 0·24 (0·11–0·54) 0·0006
Log odds community prevalence 0·52 (0·47–0·57) <0·0001 0·51 (0·47–0·56) <0·0001
Region: Asia (vs non-Asia) 0·05 (0·02–0·12) <0·0001 ·· ··
Log
10
 population size 0·23 (0·17–0·32) <0·0001 0·22 (0·16–0·31) <0·0001
Community diagnostic: usPCR 
(vs other PCR)
4·09 (2·12–7·90) <0·0001 ·· ··
Log odds bednet use 1·08 (1·00–1·18) 0·049 ·· ··
Recent intervention* ·· ·· 1·56 (1·01–2·41) 0·044
Log odds p (seek care if febrile)† ·· ·· 1·95 1·46–2·60) <0·0001
Detection of infection in both the full all-age population and detection of infections in the population older than 5 years of 
age. Some cells are empty because the factor was not retained in the adjusted analysis because they did not contribute 
to the explanatory power of the model. OR=odds ratio. usPCR=ultra-sensitive PCR. *Mass drug administrations targeting 
Plasmodium falciparum with or without concurrent long-lasting insecticidal net distribution. †The probability of patients 
seeking care if febrile is the proxy variable typically used in malaria research to provide a proxy estimate for treatment seeking.
Table 3: Fixed-effects results of the mixed-effects log-linear regression for the proportion of 
Plasmodium vivax infections detected in the health system according to community-level transmission 
intensity
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infections detected within the health system will probably 
decrease.
Passive surveillance data for malaria are generally used 
for two purposes: resource allocation and monitoring 
trends in malaria.29,30 From the resource allocation 
perspective, the magnitude of undercounting might not 
matter. The number of tests or malaria drugs to send to a 
health facility will not be affected unless additional people 
start to seek care or testing rates increase. Conversely, the 
effect on estimating current or changes in malaria burden 
could be substantial. It has long been assumed that, 
although within-catchment heterogeneity of transmission 
is not routinely represented, incident infections detected 
at the health facility are a good representation of 
transmission intensity in the community.2,15 However, 
what is identified in the health system does not account 
for non-opportunistically detected new infections in the 
immune population or when an already infected person 
receives multiple inoculations with different strains of 
parasites.31 Similarly, reductions in transmission intensity 
are not immediately detectable based on clinical incidence 
data. Once transmission declines, the first expected trend 
is a shift in the underlying age distribution of clinically 
detected cases, with older individuals presenting with 
clinical symptoms as immunity wanes in the popu-
lation.32,33 The prevalence of infected individuals, such as 
that assessed using easy access group surveys, and any 
change in the size of the parasite reservoir is arguably a 
more direct measure of progress in the short term, 
especially in a population with a large proportion of 
immune individuals.
The presence of undetected infections becomes 
especially critical in settings striving for and maintaining 
malaria elimination. A key factor initiating a shift to 
elimination strategies is routinely collected malaria 
data.30 Allowing for the time for transmission to taper off 
naturally with corresponding decreases in population-
level protective immunity, and improvements in health 
systems could be an option whereby relying on clinical 
data alone to detect all infections during the elimination 
phase might be sufficient. However, in settings acce-
lerating elimination, the potential for any residual 
population immunity masking any asymptomatic or 
introduced infections must be acknowledged.34 A better 
understanding of the probability that an infection 
becomes symptomatic and potentially detected by the 
health system will inform the critical point at which 
programmes could scale back control activities and rely 
on the health system to identify all infections (eg, 
P[Detect] of 100%). Until that point, maintaining diligent 
levels of control is essential.35
This study has some important limitations. It was a 
pooled analysis driven by a large number of clusters in a 
few countries and therefore was not powered to detect the 
specific change point whereby the majority of infections 
can be detected or the exact proportion of infections 
detected. The general trends observed are consistent with 
existing knowledge, and model fits were good despite the 
substantial variation in the data. The conclusions are 
nevertheless informative. Second, this was not a full 
systematic review and relied on secondary data analysis. 
We were unable to include all eligible community surveys 
because the ability to obtain matched PCD data was 
logistically unfeasible because of research sites being 
closed or the timeframe required to obtain local approvals 
was prohibitive. Some bias might have been introduced by 
the exclusion of some sites but the effect of this bias is 
expected to be non-differential and thus we believe our 
inferences are still valid. Similarly, because of the nature of 
this pooled analysis, not all variables of interest were 
available in all datasets, leading to derivation of the primary 
outcome variable and reliance on modelled or estimated 
covariates in some settings, potentially introducing some 
bias. However, the credible intervals were calculated 
accounting for this introduced uncertainty and the final 
model fits are consistent with known factors related to 
malaria transmission. Third, the more granular 
epidemiological considerations and differences between 
settings were not accounted for—for example, in southeast 
Asian settings, forest goers are known to be at increased 
risk of malaria infection due to the vectors’ preferred 
ecological niche, leading to a different risk profile in this 
setting.36 Accounting for the differential risk profiles can 
help make health systems more effective at detecting 
infections by adapting activities to where they are more 
likely to find them. Moreover, cases might not report to 
their nearest health facility, might seek care at private 
facilities, or be misclassified as imported or local. However, 
people from other catchments might also prefer to attend 
the included facility, resulting in non-differential mis-
classification of infections or cases. Similarly, travel history 
is used to define an infection as imported. Classification is 
generally improving, especially in low transmission 
settings where this is more relevant, but variation exists at 
both the facility and country level in how imported was 
classified. The data generated at the facility level are what 
is available for decision making so, although the data used 
here might not be perfect, we expect the resulting in-
ferences to be valid. Some care-seeking malaria infections 
might have been misclassified because of the low 
diagnostic sensitivity of rapid diagnostic tests or routine 
microscopy, which is again lower than that of molecular 
methods used to define the extent of the infected popu-
lation in the community. The aim here was to show the 
degree of bias when relying on routinely collected data to 
estimate the magnitude of malaria burden and not a direct 
comparison of two populations using different diagnostic 
tools. Finally, the P vivax data available were cross-
sectional. Infections detected might be due to relapse 
instead of being an incident infection. However, in terms 
of P(Detect), this is expected to be a non-differential bias 
and unlikely to affect the observed trends.
This study has confirmed that health facilities detect a 
small proportion of the malaria parasite reservoir, with 
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routine data underestimating transmission intensity and 
the magnitude of malaria-infected populations. When 
transmission is very low, health facilities become more 
effective at detecting infections, and this finding is 
observed for both P falciparum and P vivax. Promoting 
better health-seeking behaviour of infected individuals 
and investing in better access to care for testing would 
lead to more infections being detected and, along with 
the iterative approach of surveillance as an intervention 
as outlined by the WHO, might ultimately contribute to 
accelerating malaria elimination.
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